An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease

被引:6
|
作者
Baratto, Claudia [1 ]
Caravita, Sergio [1 ,2 ]
Soranna, Davide [3 ]
Dewachter, Celine [4 ]
Bondue, Antoine [4 ]
Zambon, Antonella [3 ,5 ]
Badano, Luigi P. [1 ,6 ]
Parati, Gianfranco [1 ,6 ]
Vachiery, Jean-Luc [4 ]
机构
[1] Osped San Luca, Dept Cardiovasc Neural & Metab Sci, Ist Auxol Italiano IRCCS, Milan, Italy
[2] Univ Bergamo, Dept Management Informat & Prod Engn, Dalmine, BG, Italy
[3] IRCCS Ist Auxol Italiano, Biostat Unit, Milan, Italy
[4] Clin Univ Bruxelles, Hop Acad Erasme, Dept Cardiol, Brussels, Belgium
[5] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy
[6] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy
关键词
hemodynamics; pulmonary hypertension; left heart disease; prognosis; RIGHT-VENTRICULAR FUNCTION; ARTERIAL CAPACITANCE; PRESSURE-GRADIENT; FAILURE; LEVOSIMENDAN; PREDICTOR; OUTCOMES; BIAS;
D O I
10.1002/pul2.12145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension (PH) is associated with a poor prognosis in left heart disease (LHD). We sought to provide an updated analysis on the association of hemodynamic variables, such as pulmonary vascular resistance (PVR), pulmonary artery compliance (PAC), and diastolic pressure gradient (DPG), with prognosis in PH-LHD, through a systematic literature review. Sixteen articles were identified, including 9600 patients with LHD, heterogeneous in terms of age, sex, and etiology of cardiac disease. In this large population, PVR (hazard ratio [HR], 1.07; 95% confidence interval [CI]: 1.05-1.0), DPG (HR, 1.02; 95% CI: 1.01-1.02) and PAC (HR, 0.76; 95% CI: 0.69-0.84) were associated with an increased risk of adverse outcome, albeit with a less solid performance of DPG. Similar results were found when hemodynamic variables were analyzed according to the thresholds commonly applied in clinical practice, or subdividing cohorts according to the underlying LHD. Furthermore, cumulative metanalysis indicated that these results are consistently stable since 2018. Thus, PVR, DPG and PAC have an established prognostic value in PH-LHD. These results are consistent through the years and unlikely to change with further studies.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: A meta-analysis
    Cao, Jacob Y.
    Wales, Kathryn M.
    Cordina, Rachael
    Lau, Edmund M. T.
    Celermajer, David S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 213 - 220
  • [2] Pulmonary hypertension due to left heart disease
    Berthelot, Emmanuelle
    Bailly, Minh Tam
    El Hatimi, Safwane
    Robard, Ingrid
    Rezgui, Hatem
    Bouchachi, Amir
    Montani, David
    Sitbon, Olivier
    Chemla, Denis
    Assayag, Patrick
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2017, 110 (6-7) : 420 - 431
  • [3] Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis
    Caravita, Sergio
    Dewachter, Celine
    Soranna, Davide
    D'Araujo, Sandy Carolino
    Khaldi, Amina
    Zambon, Antonella
    Parati, Gianfranco
    Bondue, Antoine
    Vachiery, Jean-Luc
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (04)
  • [4] Pulmonary Hypertension Due to Left Heart Disease
    Gerges, Mario
    Gerges, Christian
    Naeije, Robert
    Lang, Irene M.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 38 (05) : 662 - 676
  • [5] Pulmonary hypertension due to left heart disease: Updated Recommendations of the Cologne Consensus Conference 2011
    Rosenkranz, Stephan
    Bonderman, Diana
    Buerke, Michael
    Felgendreher, Ralf
    ten Freyhaus, Henrik
    Gruenig, Ekkehard
    de Haan, Fokko
    Hammerstingl, Christoph
    Harreuter, Alexander
    Hohenforst-Schmidt, Wolfgang
    Kindermann, Ingrid
    Kindermann, Michael
    Kleber, Franz X.
    Kuckeland, Matthias
    Kuebler, Wolfgang M.
    Mertens, Dirk
    Mitrovic, Veselin
    Opitz, Christian
    Schmeisser, Alexander
    Schulz, Uwe
    Speich, Rudolf
    Zeh, Wolfgang
    Weil, Joachim
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 154 : S34 - S44
  • [6] Prognostic Factors for Survival in Pulmonary Hypertension Due to Left Heart Disease
    Yamabe, Sayuri
    Dohi, Yoshihiro
    Fujisaki, Shinya
    Higashi, Akifumi
    Kinoshita, Hiroki
    Sada, Yoshiharu
    Hidaka, Takayuki
    Kurisu, Satoshi
    Yamamoto, Hideya
    Kihara, Yasuki
    CIRCULATION JOURNAL, 2015, 80 (01) : 243 - 249
  • [7] Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease
    Tampakakis, Emmanouil
    Shah, Sanjiv J.
    Borlaug, Barry A.
    Leary, Peter J.
    Patel, Harnish H.
    Miller, Wayne L.
    Kelemen, Benjamin W.
    Houston, Brian A.
    Kolb, Todd M.
    Damico, Rachel
    Mathai, Stephen C.
    Kasper, Edward K.
    Hassoun, Paul M.
    Kass, David A.
    Tedford, Ryan J.
    CIRCULATION-HEART FAILURE, 2018, 11 (04)
  • [8] Problematic aspects of pulmonary hypertension due to left heart disease: focus on combined postcapillary and precapillary pulmonary hypertension
    Aleevskaya, A. M.
    Vyborov, O. N.
    Gramovich, V. V.
    Martynyuk, T., V
    TERAPEVTICHESKII ARKHIV, 2020, 92 (09) : 54 - 62
  • [9] Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications
    Omote, Kazunori
    Sorimachi, Hidemi
    Obokata, Masaru
    Reddy, Yogesh N., V
    Verbrugge, Frederik H.
    Omar, Massar
    DuBrock, Hilary M.
    Redfield, Margaret M.
    Borlaug, Barry A.
    EUROPEAN HEART JOURNAL, 2022, 43 (36) : 3417 - 3431
  • [10] Pulmonary vascular gradient: A predictor of prognosis in pulmonary hypertension due to left heart disease
    Gerges, Christian
    Gerges, Mario
    Lang, Marie
    Heinzl, Harald
    Zhang, Yuhui
    Probst, Peter
    Maurer, Gerald
    Lang, Irene
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40